He Lei, Fei Fan, Zhou Chengzhi, Bai Xiaoyan, Yu Shuqing, Wang Lei, Xu Ruxiang, Liu Hanjie
Department of Neurosurgery, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Neurooncol Adv. 2025 Feb 8;7(1):vdaf035. doi: 10.1093/noajnl/vdaf035. eCollection 2025 Jan-Dec.
BACKGROUND: Approximately 8.94%-44.44% of nonenhancing adult-type diffuse gliomas are identified as glioblastomas. Our purpose is to develop a nomogram that can predict glioblastomas from nonenhancing adult-type diffuse gliomas. METHODS: Nonenhancing adult-type diffuse gliomas were collected from Beijing Tiantan Hospital and TCIA public database. Univariate and multivariate logistic regression were performed to screen features on the training set. The features with < .05 in multivariate logistic regression were used to establish the prediction model. The testing and validation sets were used to test the model. RESULTS: A total of 557 and 67 nonenhancing adult-type diffuse gliomas were collected from Beijing Tiantan Hospital and TCIA, respectively. The T2-FLAIR mismatch sign exhibited 100% specificity but low sensitivity (<30%) in ruling out glioblastoma. Age, tumor location, rADC, and rADC were identified as independent predictors and employed for developing the prediction model. The AUC of the model was 0.901, 0.861, and 0.945 in the training, testing, and validation set, respectively. The best cutoff value of nomoscore was 138.5, which achieved sensitivity of 0.935, 0.714, and 0.895, specificity of 0.777, 0.782, and 0.8775 in the training, testing, and validation sets, respectively. Survival analysis shown that patients with nomoscore above 138.5 had significantly poorer survival time than those with scores below 138.5. CONCLUSIONS: Positive T2-FLAIR mismatch sign can effectively rule out glioblastoma in nonenhancing adult-type diffuse gliomas with high specificity. Nonenhancing adult-type diffuse gliomas with nomoscore above 138.5 are highly suspicious for glioblastoma or nonglioblastoma with a poor prognosis.
AJNR Am J Neuroradiol. 2024-2-7
Ann Clin Transl Neurol. 2025-2
Cancers (Basel). 2023-4-27